Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 32 Neoplasms 12 Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 10 Colonic Neoplasms 9 Motor Activity 8 Lung Neoplasms 8 Endometrial Neoplasms 8 Colorectal Neoplasms 8 Uterine Cervical Neoplasms 7 Rectal Neoplasms 7 Obesity 7 Tobacco Use Disorder 6 Small Cell Lung Carcinoma 6 Overweight 6 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Breast Carcinoma In Situ 5 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Leukemia 4 Head and Neck Neoplasms 4 Depression 4 Carcinoma, Renal Cell 4 Carcinoma, Intraductal, Noninfiltrating 4 Stomach Neoplasms 3 Sexuality 3 Sexual Dysfunction, Physiological 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Oropharyngeal Neoplasms 3

Interventions

Temozolomide 109 Magnetic Resonance Spectroscopy 52 Bevacizumab 52 Radiotherapy 44 Irinotecan 27 Blood Specimen Collection 19 Surgical Procedures, Operative 16 Radiation 15 Aminolevulinic Acid 15 Carboplatin 13 fluorodopa F 18 12 Nivolumab 12 Radiotherapy, Intensity-Modulated 11 Carmustine 11 Radiosurgery 10 Magnetic Resonance Imaging 10 pembrolizumab 9 Topotecan 9 Specimen Handling 9 Everolimus 9 Erlotinib Hydrochloride 9 Biopsy 9 poly ICLC 8 Surveys and Questionnaires 8 Standard of Care 8 Etoposide 8 Drug Therapy 8 Lomustine 7 Filgrastim 7 Cyclophosphamide 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioma × Counseling × Clear all

NCT03775369 2022-05-18

Glioma and Exercising

University Hospital, Basel, Switzerland

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡